ROMILAST 4 mg Tablets

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

Doctor
5.0(36)

Andrei Popov

General medicinePain medicine7 years of experience

Dr. Andrei Popov is a family physician with specialized training in the management of chronic pain. He provides video consultations for adults in Spain and across Europe: whether you have been living with pain for months that no one has been able to properly explain, or you need to resolve a health issue without waiting weeks for an appointment.

His approach is clear: to listen, organize your case, and provide you with a practical roadmap based on evidence-based medicine and adapted to your medical history and personal needs.

Pain: how he can help

  • Chronic pain (more than 3 months
  • Migraine and recurrent or high-intensity headaches
  •  Neck, lower back, back and joint pain
  •  Post-traumatic pain after injuries or surgeries
  •  Pain of neurological origin: neuralgia, neuropathic pain, fibromyalgia

General medicine

  • Frequent respiratory infections (cold, flu, persistent cough)
  • Hypertension, diabetes and metabolic disorders
  • Review of laboratory tests and MRI/CT reports (explained in clear language)
  • Preventive medicine and health monitoring
  • Second opinions and treatment adjustments (when clinically appropriate)

What the consultation is like
 Each session lasts up to 30 minutes. We review symptoms, medical history, medications and any tests you provide, and you finish the consultation with a clear treatment plan, defined next steps, and criteria to understand when follow-up may be needed. If warning signs are detected, he will clearly advise whether you need in-person care or urgent medical attention.

Book a video appointment
€86
This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use Romilast

Contents of the leaflet

  1. Package Leaflet: Information for the User
  2. Romilast, 4 mg, Chewable Tablets
    1. Read the package leaflet carefully before taking the medicine, as it contains
    2. Table of Contents of the Leaflet
  3. What is Romilast and what is it used for
    1. What is Romilast
    2. How Romilast works
    3. When to use Romilast
    4. What is asthma?
  4. Important information before taking Romilast
    1. When not to give Romilast to a child
    2. Warnings and precautions
    3. Various neuropsychiatric events (such as changes in behavior and mood, depression, and suicidal tendencies) have been reported in patients of all ages treated with montelukast (see section 4). If the patient experiences such symptoms while taking montelukast, consult a doctor.
    4. Children and adolescents
    5. Romilast and other medicines
    6. Romilast with food and drink
    7. Pregnancy and breastfeeding
    8. Driving and using machines
    9. Romilast 4 mg chewable tablets contain aspartame, sodium, and mannitol
  5. How to take Romilast
    1. Children aged 2 to 5 years:
    2. If the child takes more Romilast than they should
    3. If the child misses a dose of Romilast
    4. If the child stops taking Romilast
  6. Possible side effects
    1. Severe side effects
    2. Uncommon: may affect up to 1 in 100 people
    3. Rare: may affect up to 1 in 1,000 people
    4. Very rare: may affect up to 1 in 10,000 people
    5. Other side effects reported after the medicine was marketed
    6. Very common: may affect more than 1 in 10 people
    7. Common: may affect up to 1 in 10 people
    8. Uncommon: may affect up to 1 in 100 people
    9. Rare: may affect up to 1 in 1,000 people
    10. Very rare: may affect up to 1 in 10,000 people
    11. Reporting side effects
  7. How to store Romilast
  8. Contents of the pack and other information
    1. What Romilast contains
    2. What Romilast looks like and contents of the pack
    3. Marketing authorization holder and manufacturer

Package Leaflet: Information for the User

Romilast, 4 mg, Chewable Tablets

Montelukast

Read the package leaflet carefully before taking the medicine, as it contains

important information for the patient.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours.
  • If you experience any side effects, including those not listed in this leaflet, tell your doctor or pharmacist. See section 4.

Table of Contents of the Leaflet

  • 1. What is Romilast and what is it used for
  • 2. Important information before taking Romilast
  • 3. How to take Romilast
  • 4. Possible side effects
  • 5. How to store Romilast
  • 6. Contents of the pack and other information
Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

1. What is Romilast and what is it used for

What is Romilast

Romilast is a leukotriene receptor antagonist, which blocks the action of substances called leukotrienes.

How Romilast works

Leukotrienes cause narrowing and swelling of the airways. By blocking the action of leukotrienes, Romilast relieves asthma symptoms and helps control asthma.

When to use Romilast

Your doctor has prescribed Romilast for the treatment of asthma in a child, to prevent asthma symptoms from occurring during the day and at night.

  • Romilast is used in the treatment of patients aged 2 to 5 years, in whom adequate control of asthma has not been achieved with existing medications and additional medication is necessary.
  • Romilast may also be used as an alternative to inhaled glucocorticosteroids in children aged 2 to 5 years who have not recently taken oral glucocorticosteroids for asthma and who are unable to use inhaled glucocorticosteroids.
  • Romilast also helps prevent bronchospasm caused by physical exertion in patients aged 2 years and older.

Your doctor will determine how to take Romilast based on the child's symptoms and the severity of asthma.

What is asthma?

Asthma is a chronic disease. In asthma, there are:

  • breathing difficulties caused by narrowing of the airways, which worsens and improves in response to various factors.
  • increased sensitivity of the airways, which react to many factors, such as cigarette smoke, pollen, cold air, or physical exertion.
  • swelling (inflammation) of the lining of the airways.

Asthma symptoms include coughing, wheezing, and a feeling of tightness in the chest.

2. Important information before taking Romilast

Tell your doctor about any current or past illnesses and allergies in the child.

When not to give Romilast to a child

  • if the child is allergic to montelukast or any of the other ingredients of this medicine (listed in section 6).

Warnings and precautions

Before starting Romilast, discuss it with your doctor or pharmacist.

  • If the child's asthma symptoms worsen or if there are difficulties breathing, seek medical attention immediately.
  • Romilast taken orally is not intended for the treatment of acute asthma attacks. If an attack occurs, follow the doctor's instructions. Always have a rescue inhaler with you in case of an asthma attack in the child.
  • It is essential that the child takes all asthma medications prescribed by the doctor.
  • Romilast should not be used as a replacement for other asthma medications prescribed by the doctor.
  • Remember that if the child taking asthma medications experiences symptoms such as flu-like symptoms, tingling or numbness of the hands or feet, worsening respiratory symptoms, and/or rash, seek medical attention.
  • The child should not be given acetylsalicylic acid (aspirin) or anti-inflammatory medications (also known as non-steroidal anti-inflammatory drugs or NSAIDs) if they worsen the child's asthma symptoms.

Various neuropsychiatric events (such as changes in behavior and mood, depression, and suicidal tendencies) have been reported in patients of all ages treated with montelukast (see section 4). If the patient experiences such symptoms while taking montelukast, consult a doctor.

If the patient experiences such symptoms while taking montelukast, consult a doctor.

Children and adolescents

Romilast 4 mg should not be given to children under 2 years of age. Romilast 4 mg chewable tablets are intended for children aged 2 to 5 years. Romilast 5 mg chewable tablets are intended for children aged 6 to 14 years.

Romilast and other medicines

Tell your doctor or pharmacist about all medicines given to the child currently or recently, as well as any medicines that may be given to the child, including those available without a prescription. Some medicines may affect the action of Romilast or Romilast may affect the action of other medicines taken by the child. Before starting Romilast, inform your doctor if the child is taking:

  • phenobarbital (used to treat epilepsy),
  • phenytoin (used to treat epilepsy),
  • rifampicin (used to treat tuberculosis and some other infections).

Romilast with food and drink

Romilast should not be taken during meals; the medicine should be taken at least 1 hour before meals or 2 hours after meals.

Pregnancy and breastfeeding

This section does not apply to Romilast, as it is intended for use in children aged 2 to 5 years.

Driving and using machines

This section does not apply to Romilast, as it is intended for use in children aged 2 to 5 years. However, the following information is relevant to the active substance, montelukast. It is not expected that Romilast will affect the ability to drive and use machines. However, individual responses to the medicine may vary. Some side effects (such as dizziness and drowsiness), which have been reported with Romilast, may affect the ability to drive and use machines.

Romilast 4 mg chewable tablets contain aspartame, sodium, and mannitol

This medicine contains 1.2 mg of aspartame in each 4 mg chewable tablet, equivalent to 0.674 mg of phenylalanine. Aspartame is a source of phenylalanine. It may be harmful to patients with phenylketonuria. This is a rare genetic disorder in which phenylalanine accumulates in the body due to its improper elimination. This medicine contains less than 1 mmol (23 mg) of sodium per chewable tablet, which means it is essentially 'sodium-free'. Mannitol may have a mild laxative effect.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

3. How to take Romilast

This medicine should always be taken exactly as prescribed by your doctor or pharmacist. If you are unsure, ask your doctor or pharmacist.

  • This medicine should be given to the child under adult supervision. For children who have problems taking the chewable tablet, a granule formulation is available.
  • The child should be given only one 4 mg Romilast chewable tablet once daily, as prescribed by the doctor.
  • The medicine should be taken even when the child does not have asthma symptoms, as well as when an acute asthma attack occurs.
  • The medicine should be taken orally.

Children aged 2 to 5 years:

Take one 4 mg Romilast chewable tablet once daily, in the evening. The medicine should not be taken during meals; it should be taken at least 1 hour before meals or 2 hours after meals. Ensure that the child taking Romilast does not take other medicines containing the same active substance, montelukast. This medicine is intended for oral use. The tablet should be chewed before swallowing.

If the child takes more Romilast than they should

Contact a doctor immediately. In most cases of overdose, no side effects have been observed. After overdose in children and adults, the following symptoms have been most commonly reported: abdominal pain, drowsiness, excessive thirst, headache, vomiting, and hyperactivity.

If the child misses a dose of Romilast

Give the medicine as prescribed by the doctor. If the child misses a dose, return to the usual dosing schedule - one chewable tablet once daily. Do not take a double dose to make up for the missed dose.

If the child stops taking Romilast

Romilast is effective in treating asthma in the child only if taken regularly. It is essential to continue taking the medicine as prescribed by the doctor to keep the child's asthma under control. If you have any further questions about taking the medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, Romilast can cause side effects, although not everybody gets them. During clinical trials with montelukast chewable tablets 4 mg, the most commonly reported side effects (which may occur in less than 1 in 10 people) considered to be related to the medicine were:

  • abdominal pain
  • increased thirst
  • Additionally, in clinical trials with montelukast film-coated tablets 10 mg and chewable tablets 5 mg, the following side effects were reported:
  • headache

These symptoms usually had a mild intensity and occurred more frequently in patients taking montelukast than in patients taking a placebo (a tablet that does not contain any medicine).

Severe side effects

Contact a doctor immediatelyif you experience any of the following severe side effects, which may require urgent medical attention.

Uncommon: may affect up to 1 in 100 people

  • allergic reactions, including swelling of the face, lips, tongue, and/or throat, which may cause difficulty breathing or swallowing
  • changes in behavior and mood: agitation, including aggressive behavior or hostility, depression
  • seizures

Rare: may affect up to 1 in 1,000 people

  • increased tendency to bleed
  • tremors
  • palpitations

Very rare: may affect up to 1 in 10,000 people

  • a syndrome of symptoms such as flu-like symptoms, tingling or numbness of the hands and feet, worsening respiratory symptoms, and/or rash (Churg-Strauss syndrome) (see section 2)
  • decreased platelet count
  • changes in behavior and mood: hallucinations, disorientation, suicidal thoughts and attempts
  • inflammation (inflammation) of the lungs
  • severe skin reactions (erythema multiforme), which may occur without prior symptoms
  • inflammation of the liver

Other side effects reported after the medicine was marketed

Very common: may affect more than 1 in 10 people

  • upper respiratory tract infections

Common: may affect up to 1 in 10 people

  • diarrhea, nausea, vomiting
  • rash
  • fever
  • increased liver enzyme activity

Uncommon: may affect up to 1 in 100 people

  • changes in behavior and mood: unusual dreams, including nightmares, difficulty sleeping, sleepwalking, irritability, feeling anxious, restlessness
  • dizziness, drowsiness, tingling and numbness
  • nosebleeds
  • dry mouth, indigestion
  • bruising, itching, hives
  • muscle or joint pain, muscle spasms
  • bedwetting in children
  • weakness and/or fatigue, malaise, swelling

Rare: may affect up to 1 in 1,000 people

  • changes in behavior and mood: attention disorders, memory disorders, uncontrolled movements

Very rare: may affect up to 1 in 10,000 people

  • painful, red lumps under the skin, most often on the shins (erythema nodosum),
  • changes in behavior and mood: obsessive-compulsive symptoms, stuttering

Reporting side effects

If you experience any side effects, including those not listed in this leaflet, tell your doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products: Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: 22 49-21-301, fax: 22 49-21-309. Website: https://smz.ezdrowie.gov.pl. Side effects can also be reported to the marketing authorization holder. By reporting side effects, you can help provide more information on the safety of this medicine.

5. How to store Romilast

  • Keep the medicine out of the sight and reach of children.
  • Do not use Romilast after the expiry date stated on the outer packaging and blister. The expiry date refers to the last day of the month.
  • Store in the original packaging to protect from light and moisture.
  • Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.

6. Contents of the pack and other information

What Romilast contains

  • The active substance is montelukast. Each chewable tablet contains 4 mg of montelukast as montelukast sodium.
  • The other ingredients are: mannitol, microcrystalline cellulose, low-substituted hydroxypropylcellulose, red iron oxide (E172), sodium croscarmellose, cherry flavor, aspartame (E951), magnesium stearate.

What Romilast looks like and contents of the pack

Romilast 4 mg chewable tablets are pink to red, mottled, oval, biconvex tablets with "MT4" engraved on one side and smooth on the other. Blisters in packs of: 28 tablets.

Marketing authorization holder and manufacturer

Marketing authorization holder: Ranbaxy (Poland) Sp. z o.o. ul. Idzikowskiego 16 00-710 Warsaw Poland Tel. 22 642 07 75 Manufacturer: Sun Pharmaceutical Industries Europe B.V. Polarisavenue 87 2132JH Hoofddorp Netherlands Terapia SA 124 Fabricii Street 400 632 Cluj Napoca Romania For further information, contact the marketing authorization holder's representative. Date of last revision of the leaflet:22.02.2024

Online doctors for Romilast

Discuss questions about Romilast, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

Doctor
5.0(36)

Andrei Popov

General medicinePain medicine7 years of experience

Dr. Andrei Popov is a family physician with specialized training in the management of chronic pain. He provides video consultations for adults in Spain and across Europe: whether you have been living with pain for months that no one has been able to properly explain, or you need to resolve a health issue without waiting weeks for an appointment.

His approach is clear: to listen, organize your case, and provide you with a practical roadmap based on evidence-based medicine and adapted to your medical history and personal needs.

Pain: how he can help

  • Chronic pain (more than 3 months
  • Migraine and recurrent or high-intensity headaches
  •  Neck, lower back, back and joint pain
  •  Post-traumatic pain after injuries or surgeries
  •  Pain of neurological origin: neuralgia, neuropathic pain, fibromyalgia

General medicine

  • Frequent respiratory infections (cold, flu, persistent cough)
  • Hypertension, diabetes and metabolic disorders
  • Review of laboratory tests and MRI/CT reports (explained in clear language)
  • Preventive medicine and health monitoring
  • Second opinions and treatment adjustments (when clinically appropriate)

What the consultation is like
 Each session lasts up to 30 minutes. We review symptoms, medical history, medications and any tests you provide, and you finish the consultation with a clear treatment plan, defined next steps, and criteria to understand when follow-up may be needed. If warning signs are detected, he will clearly advise whether you need in-person care or urgent medical attention.

Book a video appointment
€86
Doctor
5.0(12)

Yevgen Yakovenko

Family medicine12 years of experience

Dr. Yevgen Yakovenko is a licensed surgeon and general practitioner in Spain and Germany. He specialises in general, paediatric, and oncological surgery, internal medicine, and pain management. He offers online consultations for adults and children, combining surgical precision with therapeutic support. Dr Yakovenko works with patients across different countries and provides care in Ukrainian, Russian, English, and Spanish.

Areas of medical expertise:

  • Acute and chronic pain: headaches, muscle and joint pain, back pain, abdominal pain, postoperative pain. Identifying the cause, selecting treatment, and creating a care plan.
  • Internal medicine: heart, lungs, gastrointestinal tract, urinary system. Management of chronic conditions, symptom control, second opinions.
  • Pre- and postoperative care: risk assessment, decision-making support, follow-up after surgery, rehabilitation strategies.
  • General and paediatric surgery: hernias, appendicitis, congenital conditions, both planned and urgent surgeries.
  • Injuries and trauma: bruises, fractures, sprains, soft tissue damage, wound care, dressing, referral when in-person care is required.
  • Oncological surgery: diagnosis review, treatment planning, and long-term follow-up.
  • Obesity treatment and weight management: a medical approach to weight loss, including assessment of underlying causes, evaluation of comorbidities, development of a personalised plan (nutrition, physical activity, pharmacotherapy if needed), and ongoing progress monitoring.
  • Imaging interpretation: analysis of ultrasound, CT, MRI, and X-ray results, surgical planning based on imaging data.
  • Second opinions and medical navigation: clarifying diagnoses, reviewing current treatment plans, helping patients choose the best course of action.

Experience and qualifications:

  • 12+ years of clinical experience in university hospitals in Germany and Spain.
  • International education: Ukraine – Germany – Spain.
  • Member of the German Society of Surgeons (BDC).
  • Certified in radiological diagnostics and robotic surgery.
  • Active participant in international medical conferences and research.

Dr Yakovenko explains complex topics in a clear, accessible way. He works collaboratively with patients to analyse health issues and make evidence-based decisions. His approach is grounded in clinical excellence, scientific accuracy, and respect for each individual.

If you are unsure about a diagnosis, preparing for surgery, or want to discuss your test results – Dr Yakovenko will help you evaluate your options and move forward with confidence.

Book a video appointment
€72
Doctor
5.0(3)

Lina Travkina

Family medicine13 years of experience

Dr. Lina Travkina is a licensed family and preventive medicine doctor based in Italy. She provides online consultations for adults and children, supporting patients across all stages of care – from acute symptom management to long-term health monitoring and prevention.

Areas of medical care include:

  • Respiratory conditions: colds, flu, acute and chronic bronchitis, mild to moderate pneumonia, bronchial asthma.
  • ENT and eye conditions: sinusitis, tonsillitis, pharyngitis, otitis, infectious and allergic conjunctivitis.
  • Digestive issues: gastritis, acid reflux (GERD), IBS, dyspepsia, bloating, constipation, diarrhoea, functional bowel symptoms, intestinal infections.
  • Urological and infectious diseases: acute and recurrent cystitis, bladder and kidney infections, prevention of recurrent UTIs, asymptomatic bacteriuria.
  • Chronic conditions: hypertension, diabetes, hypercholesterolemia, metabolic syndrome, thyroid disorders, excess weight.
  • Neurological and general symptoms: headache, migraine, dizziness, fatigue, sleep disturbances, reduced concentration, anxiety, asthenia.
  • Chronic pain support: back, neck, joint, and muscle pain, tension syndromes, pain associated with osteochondrosis and chronic conditions.

Additional care areas:

  • Preventive consultations and check-up planning.
  • Medical advice and follow-up consultations.
  • Test interpretation and diagnostic guidance.
  • Structured support for undiagnosed complaints.
  • Second opinion on diagnoses and treatment plans.
  • Nutritional and lifestyle support for vitamin deficiencies, anaemia, metabolic issues.
  • Post-operative recovery support and pain management.
  • Preconception counselling and postpartum support.
  • Immunity support and strategies to reduce frequency of infections.

Dr. Travkina combines evidence-based medicine with an attentive, personalised approach. Her consultations focus not only on treatment, but also on prevention, recovery, and long-term wellbeing.

If during the consultation it becomes clear that your case requires in-person assessment or specialised care outside of her scope, the session will be terminated and the payment fully refunded.

Book a video appointment
€75
Doctor
5.0(2)

Dmytro Horobets

Family medicineEndocrinology7 years of experience

Dr. Dmytro Horobets is a licensed family medicine physician in Poland, specialising in endocrinology, diabetology, obesity management, gastroenterology, pediatrics, general surgery, and pain medicine. He offers online consultations for adults and children, providing personalised medical support for a wide range of acute and chronic health concerns.

Areas of expertise:

  • Endocrinology: diabetes type 1 and type 2, prediabetes, thyroid disorders, metabolic syndrome, hormonal imbalance.
  • Obesity medicine: structured weight management plans, nutritional counselling, obesity-related health risks.
  • Gastroenterology: acid reflux (GERD), gastritis, irritable bowel syndrome (IBS), liver and biliary conditions.
  • Pediatric care: infections, respiratory symptoms, digestive issues, growth and development monitoring.
  • General surgery support: pre- and post-surgical consultations, wound care, rehabilitation.
  • Pain management: chronic and acute pain, back pain, joint pain, post-traumatic pain syndromes.
  • Cardiovascular health: hypertension, cholesterol control, risk assessment for heart disease.
  • Preventive medicine: regular check-ups, health screenings, long-term management of chronic conditions.

Dr. Horobets combines evidence-based medicine with a patient-centred approach. He carefully evaluates each patient’s medical history and symptoms, offering clear explanations and structured treatment plans adapted to individual needs.

Whether you need help managing diabetes, tackling weight-related health issues, interpreting lab results, or receiving general family medicine support, Dr. Horobets provides professional online care tailored to your specific health goals.

Book a video appointment
€71
Doctor
5.0(19)

Nuno Tavares Lopes

Family medicineGeneral medicine18 years of experience

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Book a video appointment
€70

Get Romilast Prescription Online

1

Fill in a 2-min form

Tell us your symptoms, history, and what medicine you're requesting.

2

Pick a doctor or let us assign

Choose a specialist or we'll match you with the next available doctor.

3

Doctor reviews your case

Usually within 30 minutes. They may ask follow-up questions via chat.

4

Collect from any pharmacy

Electronic prescription sent to your email — valid across Spain.

Frequently Asked Questions

Is a prescription required for Romilast?

Romilast requires a prescription in Poland. You can check with a doctor online whether this medicine may be appropriate for your situation.

What is the active substance in Romilast?

The active ingredient in Romilast is montelukast. This information helps identify medicines with the same composition but different brand names.

Who manufactures Romilast?

Romilast is manufactured by Sun Pharmaceuticals Industries Europe B.V. Terapia S.A.. Pharmacy brands and packaging may differ depending on the distributor.

Which doctors can assess the use of Romilast online?

Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether Romilast is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.

How to buy Romilast in Spain?

Spain has a well-developed healthcare infrastructure across major cities such as Madrid, Barcelona, Valencia, and Seville. Pharmacies are widely available and operate under strict regulations, ensuring access to prescribed medications.

You can buy Romilast in Madrid, Barcelona, Seville, or Valencia at any local pharmacy with a valid prescription.

To obtain a prescription, you can use Oladoctor:

What are the alternatives to Romilast?

Other medicines with the same active substance (montelukast) include Asmenol Pph, Asmenol Pph, Asmenol. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media